Current Opinion in Supportive and Palliative Care was launched in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of supportive and palliative care are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Aminah Jatoi, MD is a practicing oncologist at the Mayo Clinic in Rochester, Minnesota, USA. She carries a strong interest in a variety of cancer-related palliative care issues, including the management of weight loss in patients with advanced cancer.
Professor Kenneth Fearon is Professor of Surgical Oncology at Edinburgh University, UK and Consultant Surgeon at the Western General Hospital, Edinburgh. He was first awarded his Bachelor of Medicine and Bachelor of Surgery (MBBCh Hons) by the University of Glasgow, UK, in 1982, and this was later followed up by his MD in 1986 from the same institution. He is a Fellow Royal College of Physicians and Surgeons (FRCPS), Glasgow, 1988; Fellow Royal College of Surgeons (FRCS), Edinburgh ad eundem 1996; Fellow Royal College of Surgeons (FRCS), England ad eundem 1997.
He is the author of over 120 peer reviewed publications on aspects of human nutrition, surgical metabolism and nutritional oncology.
Amy P. Abernethy
Amy P. Abernethy, MD, a medical oncologist, is Director of the Duke Center for Learning Health Care (CLHC) in the Duke Clinical Research Institute, and Director of the Duke Cancer Care Research Program (DCCRP) in the Duke Cancer Institute, USA. An internationally recognized expert in health services research and delivery in patient-centered cancer care, especially pain, symptom management and palliative care, she directs a prolific research program (CLHC/DCCRP) which conducts patient-centered clinical trials, analyses, and policy studies; all CLHC/DCCRP studies make use of, and simultaneously contribute to the development of, an integrated data system that coordinates diverse datasets, leverages novel information technology for patient-reporting of symptoms and other concerns, informs future studies, and facilitates patient education and patient-provider communication. Patient reported information is central to this work.
As a part of her focus on health policy, evidence synthesis, and comparative effectiveness research, Dr Abernethy is Co-Chair of the National Institutes of Health (NIH)-funded Palliative Care Research Cooperative Group (PCRC), an appointee to the Institute of Medicine's National Cancer Policy Forum, President-Elect of the American Academy of Hospice & Palliative Medicine, on the Board of Directors for the Personalized Medicine Coalition, on the Advisory Board for the Rapid Learning System for Cancer of the American Society of Clinical Oncology, and she is and Co-Principal Investigator of a NIH-funded faculty development (K01) program in comparative effectiveness research at Duke. Dr Abernethy participates integrally in current high-level national and international discussions about reforming the evidence development system, presenting a model for a rapid learning cancer clinic that coordinates clinical and research functions to better serve patients’ needs in an evidence-driven, cost-effective, and patient-centered manner.
David C. Currow
David Currow is currently the Professor of the Discipline of Palliative and Supportive Services at Flinders University, Adelaide, Australia.
Since 2000 he has had the Chair of Palliative and Supportive Services at Flinders University where there are more than 200 distance students studying at a post-graduate level around the world from a variety of discipline backgrounds. He has published widely in palliative care journals and the general medical literature. Among other projects, he is Co-Chief Investigator on an anthology of evidence for palliative care practice and service delivery – http://www.caresearch.com.au. Other research interests include the symptomatic management of dyspnoea, improving population based planning for people with life limiting illnesses and improving the evidence base around which clinical decisions are made in palliative care.
Funded projects include NIH funding for an international multi-site randomised controlled trial on the use of oxygen versus medical air in people who do not quality for long term home oxygen. He is a current fund holder of National Health and Medical Research Council grants in Australia and has lead a national palliative care clinical trials program funded for more than $10milllion by the Australian government over the last four years. He is still an active teacher and this year was part of a team who received the Vice Chancellors Teaching Award at Flinders University.
He is a senior Associate Editor of the Journal of Palliative Medicine.
Deborah W. Bruner
Dr Deborah Watkins Bruner, RN, PhD, FAAN, is the Robert W. Woodruff Professor of Nursing in the Nell Hodgson Woodruff School of Nursing, Professor of Radiation Oncology, and Associate Director for Outcomes Research, Winship Cancer Institute, Emory University, USA. She moved a year ago from the University of Pennsylvania where she was the Director, Biobehavioral Research Center, Interim Associate Dean for Research in the School of Nursing, and Co-Program Leader, Cancer Prevention and Control Program, Abramson Cancer Center, USA.
Dr Bruner is the National Cancer Institute (NCI)-sponsored Radiation Therapy Oncology Group (RTOG) Community Clinical Oncology Program (CCOP) Principal Investigator. She is also Vice Chair for Outcomes for RTOG, a clinical trials research consortium of over 300 sites across the United States and Canada. Dr Bruner serves as co-chair of the NCI Symptom Management and Health Related Quality of Life Steering Committee, served on the NCI Clinical Trials Advisory Committee for 4 years, served on the Clinical Trials Evaluation Working Group, and currently serves on the NCI National Clinical Trials Network (NCTN) Working Group. She was co-chair of the 2011 NCI Clinical Trials Planning meeting on Patient Reported Outcomes.
Dr Bruner's research focuses on symptom management and supportive care across cancer sites, quality of life, patient reported outcomes (PROs), decision-making, preferences and utilities for cancer therapies, and health disparities in recruitment to clinical trials. Dr Bruner earned her PhD in Nursing at the University of Pennsylvania in 1999 and has been continuously funded since 1998 from sponsors including the American Cancer Society, Department of Defense, Oncology Nursing Society, State of Pennsylvania, National Institute of Nursing Research and the National Institutes of Health. Her articles have been published in a number of leading journals including the Journal of Clinical Oncology, the New England Journal of Medicine, the International Journal of Radiation Oncology, Biology, Physics and Cancer.